Abbott Laboratories
(NYSE:ABT)
$101.86
-0.20[-0.20%]
Last update: 5:02PM (Delayed 15-Minutes)
Get Real Time Here
$101.86
0[0.00%]
After-Hours
Open-Close-
Vol / Avg.331.000 / 5.622MMkt Cap176.835B
Day Range- - -52 Wk Range89.674 - 115.830

Abbott Laboratories Stock (NYSE:ABT), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$144.00

Lowest Price Target1

$104.00

Consensus Price Target1

$120.33

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
206301

Analyst Firms Making Recommendations1

  • Morgan Stanley
  • Wells Fargo
  • Raymond James
  • Barclays
  • Mizuho

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Abbott Laboratories

Upgrades (2)

Downgrades (0)

Initiations (6)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
10/19/2023ABTBuy Now
Abbott Laboratories
$101.865.05%Morgan Stanley
David Lewis
$112 → $107MaintainsEqual-WeightGet Alert
10/19/2023ABTBuy Now
Abbott Laboratories
$101.8613.88%Wells Fargo
Lawrence Biegelsen
$136 → $116MaintainsOverweightGet Alert
10/19/2023ABTBuy Now
Abbott Laboratories
$101.867.99%Raymond James
Jayson Bedford
$123 → $110MaintainsOutperformGet Alert
07/24/2023ABTBuy Now
Abbott Laboratories
$101.8629.59%Barclays
Matt Miksic
$127 → $132MaintainsOverweightGet Alert
07/21/2023ABTBuy Now
Abbott Laboratories
$101.869.95%Morgan Stanley
David Lewis
$112 → $112ReiteratesEqual-Weight → Equal-WeightGet Alert
07/21/2023ABTBuy Now
Abbott Laboratories
$101.8612.9%Mizuho
Anthony Petrone
$110 → $115AssumesNeutral → NeutralGet Alert
07/21/2023ABTBuy Now
Abbott Laboratories
$101.86Wolfe Research
Mike Polark
UpgradeUnderperform → Peer PerformGet Alert
04/20/2023ABTBuy Now
Abbott Laboratories
$101.8627.63%UBS
Matthew Korn
$117 → $130MaintainsBuyGet Alert
04/20/2023ABTBuy Now
Abbott Laboratories
$101.8620.75%Raymond James
Jayson Bedford
$116 → $123MaintainsOutperformGet Alert
04/20/2023ABTBuy Now
Abbott Laboratories
$101.8624.68%Barclays
Matt Miksic
$125 → $127MaintainsOverweightGet Alert
04/20/2023ABTBuy Now
Abbott Laboratories
$101.8627.63%Citigroup
Joanne Wuensch
$125 → $130MaintainsBuyGet Alert
04/17/2023ABTBuy Now
Abbott Laboratories
$101.8627.63%BTIG
Ryan Zimmerman
$125 → $130MaintainsBuyGet Alert
04/17/2023ABTBuy Now
Abbott Laboratories
$101.8613.88%Raymond James
Jayson Bedford
$123 → $116MaintainsOutperformGet Alert
04/10/2023ABTBuy Now
Abbott Laboratories
$101.8633.52%Wells Fargo
Lawrence Biegelsen
$140 → $136MaintainsOverweightGet Alert
04/05/2023ABTBuy Now
Abbott Laboratories
$101.8633.52%Wells Fargo
Larry Biegelsen
$140 → $136MaintainsOverweightGet Alert
01/22/2022ABTBuy Now
Abbott Laboratories
$101.8622.72%JP Morgan
Robbie Marcus
→ $125MaintainsOverweightGet Alert
07/22/2022ABTBuy Now
Abbott Laboratories
$101.8622.72%JP Morgan
Robbie Marcus
→ $125MaintainsOverweightGet Alert
08/01/2021ABTBuy Now
Abbott Laboratories
$101.8627.63%Jefferies
Raj Denhoy
$123 → $130MaintainsBuyGet Alert
08/23/2021ABTBuy Now
Abbott Laboratories
$101.8637.44%TD Cowen
Joshua Jennings
$125 → $140MaintainsOutperformGet Alert
Q

What is the target price for Abbott Laboratories (ABT)?

A

The latest price target for Abbott Laboratories (NYSE: ABT) was reported by Morgan Stanley on October 19, 2023. The analyst firm set a price target for $107.00 expecting ABT to rise to within 12 months (a possible 5.05% upside). 27 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Abbott Laboratories (ABT)?

A

The latest analyst rating for Abbott Laboratories (NYSE: ABT) was provided by Morgan Stanley, and Abbott Laboratories maintained their equal-weight rating.

Q

When is the next analyst rating going to be posted or updated for Abbott Laboratories (ABT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abbott Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abbott Laboratories was filed on October 19, 2023 so you should expect the next rating to be made available sometime around October 19, 2024.

Q

Is the Analyst Rating Abbott Laboratories (ABT) correct?

A

While ratings are subjective and will change, the latest Abbott Laboratories (ABT) rating was a maintained with a price target of $112.00 to $107.00. The current price Abbott Laboratories (ABT) is trading at is $101.86, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.